We are live on ! Find out more
NGEN

NervGen Pharma
NGEN

45 hedge funds and large institutions have $6.42M invested in NervGen Pharma in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11,370% more capital invested

Capital invested by funds: $56K → $6.42M (+$6.37M)

4,400% more funds holding

Funds holding: 1 → 45 (+44)

2.1% more ownership

Funds ownership: 0% → 2.1% (+2.1%)

Holders
45
Holders Change
+44
Holders Change %
+4,400%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
PI
PFG Investments
New York
+$871K
2
Bank of America
Bank of America
North Carolina
+$869K
3
Marshall Wace
Marshall Wace
United Kingdom
+$868K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$745K
5
IWC
Integrated Wealth Concepts
Massachusetts
+$376K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
26
Mariner
Kansas
$67.4K +$77.4K +17,875 New
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$59K +$67.2K +15,504 New
LPL Financial
28
LPL Financial
California
$50.5K +$58K +13,400 New
SC
29
Scotia Capital
Ontario, Canada
$49.1K +$56.3K +12,998 New
Creative Planning
30
Creative Planning
Kansas
$48.8K +$56K +12,937 New
Morgan Stanley
31
Morgan Stanley
New York
$45.2K +$51.9K +11,982 New
ATPW
32
Ashton Thomas Private Wealth
Arizona
$40.3K +$46.4K +10,700 New
CIBC World Market
33
CIBC World Market
Ontario, Canada
$39.8K +$45.7K +10,560 New
FLPIM
34
F.L. Putnam Investment Management
Massachusetts
$38.5K +$44.2K +10,200 New
PP
35
Paladin Partners
Wisconsin
$37.7K – – –
DOA
36
D'Orazio & Associates
Virginia
$37.7K +$43.3K +10,000 New
APW
37
Aventura Private Wealth
Florida
$25.9K +$29.8K +6,880 New
AF
38
Allworth Financial
California
$22.6K +$26K +6,000 New
SPIA
39
Steward Partners Investment Advisory
New York
$15.5K +$17.8K +4,103 New
SAM
40
Smartleaf Asset Management
Massachusetts
$13.6K +$15.8K +3,656 New
Jones Financial Companies
41
Jones Financial Companies
Missouri
$3.66K +$4.33K +1,000 New
National Bank of Canada
42
National Bank of Canada
Quebec, Canada
$3.13K +$3.61K +833 New
MCM
43
MAI Capital Management
Ohio
$2.64K +$3.03K +700 New
Simplex Trading
44
Simplex Trading
Illinois
$101 +$117 +27 New
CIAM
45
Caitong International Asset Management
Hong Kong
$4 +$4 +1 New
1
2

NGEN Hedge Fund Activity: Q1 2026 in Review

45 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in NervGen Pharma (NGEN) for Q1 2026, worth a combined $6.42M — up 11,370% from $56K a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NGEN positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PFG Investments, opening a new position worth an estimated $871K.

  • 45 institutional investors held NervGen Pharma (NGEN) as of Q1 2026, up from 1 in Q4 2025.
  • Funds reported $6.42M of NervGen Pharma stock for Q1 2026, up 11,370% quarter-over-quarter.
  • 44 funds opened new NervGen Pharma positions in Q1 2026 and 0 closed out, a net change of +44 holders.
  • The largest NervGen Pharma buyer in Q1 2026 was PFG Investments, an estimated $871K added.

Based on aggregated 13F filings for Q1 2026.